1-12 of 12
Peter Joosten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

Marcel Nijland, MD, Karin Boslooper, MD, Anke Van den Berg, PhD, Hanneke C. Kluin-Nelemans, MD PhD, Peter Joosten, MD, Huib Storm, MD PhD, Robby Kibbelaar, MD PhD, Gustaaf van Imhoff, MD PhD, Mels Hoogendoorn, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1503.
https://doi.org/10.1182/blood.V126.23.1503.1503
Published: 2015
Journal Articles

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Berdien Oortgiesen, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Robby Kibbelaar, MD PhD, Huib Storm, PhD, Sjoerd Hovenga, MDPhD, Bas P Van Rees, MD PhD, Gerhard Woolthuis, MD, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2136.
https://doi.org/10.1182/blood.V124.21.2136.2136
Published: 2014
Journal Articles

Thalidomide Combined With High Dose Melphalan Improves Event Free and Overall Survival In Patients With Newly Diagnosed Multiple Myeloma: Extended Follow-Up Of The HOVON-50 Trial

Henk Lokhorst, Bronno van der Holt, PhD, Sonja Zweegman, MD PhD, Edo Vellenga, MD, PhD, Sandra Croockewit, MD, Marinus H.J. Van Oers, MD, PhD, Peter von dem Borne, MD, PhD, Pierre W. Wijermans, MD, PhD, M. R Schaafsma, MD, PhD, Okke de Weerdt, Shulamiet Wittebol, MD, Michel Delforge, MD, PhD, Gerard M.J. Bos, Prof MD PhD, Harm Sinnige, Marinus MarwijkKooy, Peter Joosten, MD, Monique C. Minnema, MD PhD, Rianne Ammerlaan, Pieter Sonneveld, MD, Ph.D
Journal: Blood
Blood (2013) 122 (21): 3332.
https://doi.org/10.1182/blood.V122.21.3332.3332
Published: 2013
Journal Articles

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Karin Boslooper, Peter Joosten, MD, Nic J.G.M. Veeger, PhD, Robby Kibbelaar, MD, PhD, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, MD, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2642.
https://doi.org/10.1182/blood.V120.21.2642.2642
Published: 2012
Journal Articles

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

André Wieringa, PharmD, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Tim Beerden, B.Sc, Huib Storm, PhD, Robby Kibbelaar, MD, PhD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3656.
https://doi.org/10.1182/blood.V120.21.3656.3656
Published: 2012
Journal Articles

Cost-Effectiveness of Rituximab As Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Population Based Study

Hedwig M Blommestein, Djamila E Issa, MD, Marjolein Pompen, PhD, Cédric Révil, Mels Hoogendoorn, MD, PhD, Peter Joosten, MD, Sonja Zweegman, MD, PhD, Peter C. Huijgens, MD, PhD, Carin A. Uyl-de Groot, PhD
Journal: Blood
Blood (2012) 120 (21): 4277.
https://doi.org/10.1182/blood.V120.21.4277.4277
Published: 2012
Journal Articles

Influence of Prophylactic Platelet Transfusions on the Recovery of Bone Marrow Function After Intensive Chemotherapy for Acute Myeloid Leukemia.

Roland MH Kivit, Peter Joosten, Mels Hoogendoorn, Joost TM De Wolf
Journal: Blood
Blood (2010) 116 (21): 1118.
https://doi.org/10.1182/blood.V116.21.1118.1118
Published: 2010
Journal Articles

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Edo Vellenga, Sandra Croockewit, Marinus H. van Oers, Peter von dem Borne, Pierre Wijermans, Ron Schaafsma, Okke de Weerdt, Shulamiet Wittebol, Michel Delforge, Henriëtte Berenschot, Gerard M. Bos, Kon-Siong G. Jie, Harm Sinnige, Marinus van Marwijk-Kooy, Peter Joosten, Monique C. Minnema, Rianne van Ammerlaan, Pieter Sonneveld, for Dutch-Belgian Hemato-Oncology Group (HOVON)
Journal: Blood
Blood (2010) 115 (6): 1113–1120.
https://doi.org/10.1182/blood-2009-05-222539
Published: 2010
Journal Articles

Unsuccessful Treatment with Lenalidomide in a Diamond-Blackfan Anemia Patient.

Peter Joosten, Mels Hoogendoorn, Huib Storm, Robby Kibbelaar
Journal: Blood
Blood (2009) 114 (22): 4219.
https://doi.org/10.1182/blood.V114.22.4219.4219
Published: 2009
Journal Articles

HemoBase: A Multidisciplinary Registration Systeem in Hemato-Oncology.

Peter Joosten, MD, Mels Hoogendoorn, MD, Huib Storm, Phd, Robby E. Kibbelaar, Phd
Journal: Blood
Blood (2006) 108 (11): 5506.
https://doi.org/10.1182/blood.V108.11.5506.5506
Published: 2006
Journal Articles

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

Clinical Trials & Observations
Annuska M. Glas, Marie José Kersten, Leonie J. M. J. Delahaye, Anke T. Witteveen, Robby E. Kibbelaar, Arno Velds, Lodewyk F. A. Wessels, Peter Joosten, Ron M. Kerkhoven, René Bernards, Johan H. J. M. van Krieken, Philip M. Kluin, Laura J. van't Veer, Daphne de Jong
Journal: Blood
Blood (2005) 105 (1): 301–307.
https://doi.org/10.1182/blood-2004-06-2298
Published: 2005
Includes: Supplemental data
Journal Articles

Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes

J.H. Frederik Falkenburg, Amon R. Wafelman, Peter Joosten, Willem M. Smit, Cornelis A.M. van Bergen, Rian Bongaerts, Ellie Lurvink, Menno van der Hoorn, Petra Kluck, James E. Landegent, Hanneke C. Kluin-Nelemans, Willem E. Fibbe, Roel Willemze
Journal: Blood
Blood (1999) 94 (4): 1201–1208.
https://doi.org/10.1182/blood.V94.4.1201
Published: 1999